FibroBiologics, Inc. - Common Stock (FBLG) Institutional Ownership

13F Institutional Holders and Ownership History from Q1 2024 to Q4 2025

Type / Class
Equity / Common Stock
Symbol
FBLG on Nasdaq
Shares outstanding
37,544,900
Price per share
$0.38
All holders as of 31 Dec 2025
Q4 2025
Total 13F shares
4,416,094
Total reported value
$993,769
% of total 13F portfolios
0%
Share change
-976,613
Value change
-$1,026,432
Number of holders
44
Price from insider filings
$0.38
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of FibroBiologics, Inc. - Common Stock (FBLG) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
O'HEERON PETE 18% $7,229,517 6,951,459 Pete O'Heeron 31 Jan 2024
Newlin Michael F. 5.6% $1,857,322 2,134,853 Mike Newlin 09 Aug 2024
BlackRock, Inc. 2% -62% $467,209 -$644,162 750,898 -58% BlackRock, Inc. 30 Jun 2025

As of 31 Dec 2025, 44 institutional investors reported holding 4,416,094 shares of FibroBiologics, Inc. - Common Stock (FBLG). This represents 12% of the company’s total 37,544,900 outstanding shares.

Top 25 Institutional Shareholders

The largest institutional shareholders of FibroBiologics, Inc. - Common Stock (FBLG) together control 11% of the company’s outstanding shares — a level of ownership often associated with strong institutional conviction and long‑term capital commitment.

Institution Ownership % Shares Held Share Change % Portfolio % Holdings Value
VANGUARD GROUP INC 3.2% 1,216,341 -1.4% 0% $273,677
BlackRock, Inc. 1.3% 482,401 +9.7% 0% $108,492
GEODE CAPITAL MANAGEMENT, LLC 0.93% 348,761 +21% 0% $78,470
Cascade Financial Partners, LLC 0.84% 314,581 +5.5% 0.01% $70,749
MILLENNIUM MANAGEMENT LLC 0.77% 288,496 -35% 0% $64,883
RENAISSANCE TECHNOLOGIES LLC 0.62% 231,600 +287% 0% $52,087
JANE STREET GROUP, LLC 0.4% 149,763 0% $33,682
AMG National Trust Bank 0.37% 138,960 0% $31,266
UBS Group AG 0.32% 120,770 +56% 0% $27,173
STATE STREET CORP 0.3% 111,300 0% 0% $25,031
Optivise Advisory Services LLC 0.29% 110,100 0% 0.01% $24,761
Requisite Capital Management, LLC 0.29% 109,713 0% 0% $24,674
&PARTNERS 0.27% 100,000 0% 0% $22,490
Cerity Partners LLC 0.25% 93,919 -25% 0% $21,122
American Institute for Advanced Investment Management, LLP 0.23% 88,206 0% 0.01% $19,838
SAXON INTERESTS, INC. 0.15% 57,000 +38% 0% $12,819
BANK OF AMERICA CORP /DE/ 0.13% 48,176 +0% 0% $10,792
NORTHERN TRUST CORP 0.13% 47,674 0% 0% $10,722
RMR Wealth Builders 0.1% 38,360 0% 0% $8,627
XTX Topco Ltd 0.1% 37,919 0% $8,528
Concurrent Investment Advisors, LLC 0.09% 35,283 0% 0% $7,935
DRW Securities, LLC 0.09% 33,348 0% $7,499
Ethos Financial Group, LLC 0.07% 24,424 0% 0% $5,493
RAYMOND JAMES FINANCIAL INC 0.05% 18,642 0% 0% $4,193
Tower Research Capital LLC (TRC) 0.05% 18,109 +6.8% 0% $4,073

Institutional Holders of FibroBiologics, Inc. - Common Stock (FBLG) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2025 Q4 4,416,094 $993,769 -$1,026,432 $0.22 44
2025 Q3 5,392,707 $3,279,712 -$9,123 $0.55 53
2025 Q2 5,921,766 $3,689,450 -$927,969 $0.62 57
2025 Q1 6,398,618 $5,758,906 +$306,126 $0.90 63
2024 Q4 5,925,974 $11,853,211 +$884,927 $2.00 63
2024 Q3 5,458,643 $16,806,221 +$3,238,257 $3.09 59
2024 Q2 3,440,451 $17,167,348 +$13,438,711 $4.99 50
2024 Q1 479,357 $5,180,994 +$5,008,953 $10.81 16